Severe impairment of dendritic cell allostimulatory activity by Sendai virus vectors is overcome by matrix protein gene deletion

Journal of Immunology

Volumn 175, Issue 8, 2005, Pages 4971-4980

  Armeanu, Sorin ^a   Bitzer, Michael ^a   Smirnow, Irina ^a   Bossow, Sascha ^b   Appel, Silke ^a   Ungerechts, Guy ^a   Bernloehr, Christian ^a   Neubert, Wolfgang J ^b   Lauer, Ulrich M ^a   Brossart, Peter ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MATRIX PROTEIN; PROTEIN SEV; UNCLASSIFIED DRUG; VIRUS VECTOR;

ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; GENE DELETION; GENE EXPRESSION; GENETIC MANIPULATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; PRIORITY JOURNAL; SENDAI VIRUS; SENDAI VIRUS VECTOR; T LYMPHOCYTE; VIRUS GENE; VIRUS RECOMBINANT;

EID: 26844520701     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.8.4971     Document Type: Article

References (52)

1. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
2. + T cells. J. Clin. Invest. 94: 797-807.
3. Raftery, M. J., A. A. Kraus, R. Ulrich, D. H. Kruger, and G. Schonrich. 2002. Hantavirus infection of dendritic cells. J. Virol. 76: 10724-10733.
4. Brossart, P., A. W. Goldrath, E. A. Butz, S. Martin, and M. J. Bevan. 1997. Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL. J. Immunol. 158: 3270-3276.
5. Kruse, M., O. Rosorius, F. Kratzer, G. Stelz, C. Kuhnt, G. Schuler, J. Hauber, and A. Steinkasserer. 2000. Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity. J. Virol. 74: 7127-7136.
6. Cameron, P. U., M. G. Lowe, F. Sotzik, A. F. Coughlan, S. M. Crowe, and K. Shortman. 1996. The interaction of macrophage and non-macrophage tropic isolates of HIV-1 with thymic and tonsillar dendritic cells in vitro. J. Exp. Med. 183: 1851-1856.
7. Fugier-Vivier, I., C. Servet-Delprat, P. Rivailler, M. C. Rissoan, Y. J. Liu, and C. Rabourdin-Combe. 1997. Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J. Exp. Med. 186: 813-823.
8. + T cells. J. Exp. Med. 186: 801-812.
9. Brossart, P., S. Wirths, W. Brugger, and L. Kanz. 2001. Dendritic cells in cancer vaccines. Exp. Hematol. 29: 1247-1255.
10. Bubenik, J. 2001. Genetically engineered dendritic cell-based cancer vaccines. Int. J. Oncol. 18: 475-478.
11. Brossart, P., G. Stuhler, T. Flad, S. Stevanovic, H. G. Rammensee, L. Kanz, and W. Brugger. 1998. Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes. Cancer Res. 58: 732-736.
12. Humrich, J., and L. Jenne. 2003. Viral vectors for dendritic cell-based immunotherapy. Curr. Top. Microbiol. Immunol. 276: 241-259.
13. Grunebach, F., M. R. Muller, A. Nencioni, and P. Brossart. 2003. Delivery of tumor-derived RNA for the induction of cytotoxic T-lymphocytes. Gene Ther. 10: 367-374.
14. Bitzer, M., S. Armeanu, U. M. Lauer, and W. J. Neubert. 2003. Sendai virus vectors as an emerging negative-strand RNA viral vector system. J. Gene Med. 5: 543-553.
15. Ikeda, Y., Y. Yonemitsu, T. Sakamoto, T. Ishibashi, H. Ueno, A. Kato, Y. Nagai, M. Fukumura, H. Inomata, M. Hasegawa, and K. Sueishi. 2002. Recombinant Sendai virus-mediated gene transfer into adult rat retinal tissue: efficient gene transfer by brief exposure. Exp. Eye Res. 75: 39-48.
16. Yonemitsu, Y., C. Kitson, S. Ferrari, R. Farley, U. Griesenbach, D. Judd, R. Steel, P. Scheid, J. Zhu, P. K. Jeffery, et al. 2000. Efficient gene transfer to airway epithelium using recombinant Sendai virus. Nat. Biotechnol. 18: 970-973.
17. Tokusumi, T., A. Iida, T. Hirata, A. Kato, Y. Nagai, and M. Hasegawa. 2002. Recombinant Sendai viruses expressing different levels of a foreign reporter gene. Virus Res. 86: 33-38.
18. Armeanu, S., G. Ungerechts, C. Bernloehr, S. Bossow, M. Gregor, W. J. Neubert, U. M. Lauer, and M. Bitzer. 2003. Cell cycle independent infection and gène transfer by recombinant Sendai viruses. J. Virol. Methods 108: 229-233.
19. Chanock, R. M., B. R. Murphy, and P. L. Collins. 2001. Parainfluenza viruses. In Fields Virology. D. M. Knipe and P. M. Howley, eds. Lippincott Williams and Wilkins, Philadelphia, pp. 1341-1379.
20. Lopez, C. B., A. Garcia-Sastre, B. R. Williams, and T. M. Moran. 2003. Type I interferon induction pathway, but not released interferon, participates in the maturation of dendritic cells induced by negative-strand RNA viruses. J. Infect. Dis. 187: 1126-1136.
21. Larsson, M., A. S. Beignon, and N. Bhardwaj. 2004. DC-virus interplay: a double edged sword. Semin. Immunol. 16: 147-161.
22. Schneider-Schaulies, S., K. Bieback, E. Avota, I. Klagge, and V. ter Meulen. 2002. Regulation of gene expression in lymphocytes and antigen-presenting cells by measles virus: consequences for immunomodulation. J. Mol. Med. 80: 73-85.
23. Leyrer, S., W. J. Neubert, and R. Sedlmeier. 1998. Rapid and efficient recovery of Sendai virus from cDNA: factors influencing recombinant virus rescue. J. Virol. Methods 75: 47-58.
24. Sigmund, M., H. Einberger, and W. J. Neubert. 1988. Simple method for rapid and highly sensitive detection of antiviral-antibodies in serum and cerebrospinal fluid of small laboratory animals. J. Virol. Methods 22: 231-238.
25. Bernloehr, C., S. Bossow, G. Ungerechte, S. Armeanu, W. J. Neubert, U. M. Lauer, and M. Bitzer. 2004. Efficient propagation of single gene deleted recombinant Sendai virus vectors. Virus Res. 99: 193-197.
26. Brossart, P., F. Grunebach, G. Stuhler, V. L. Reichardt, R. Mohle, L. Kanz, and W. Brugger. 1998. Generation of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte-macrophage colony-stimulating factor. Blood 92: 4238-4247.
27. Bitzer, M., S. Armeanu, F. Prinz, G. Ungerechte, W. Wybranietz, M. Spiegel, C. Bernlohr, F. Cecconi, M. Gregor, W. J. Neubert, et al. 2002. Caspase-8 and Apaf-1-independent caspase-9 activation in Sendai virus-infected cells. J. Biol. Chem. 277: 29817-29824.
28. Samady, L., E. Costigliola, L. MacCormac, Y. McGrath, S. Cleverley, C. E. Lilley, J. Smith, D. S. Latchman, B. Chain, and R. S. Coffin. 2003. Deletion of the virion host shutoff protein (vhs) from herpes simplex virus (HSV) relieves the viral block to dendritic cell activation: potential of vhs- HSV vectors for dendritic cell-mediated immunotherapy. J. Virol. 77: 3768-3776.
29. Bitzer, M., F. Prinz, M. Bauer, M. Spiegel, W. J. Neubert, M. Gregor, K. Schulze-Osthoff, and U. Lauer. 1999. Sendai virus infection induces apoptosis through activation of caspase-8 (FLICE) and caspase-3 (CPP32). J. Virol. 73: 702-708.
30. Tropea, F., L. Troiano, D. Monti, E. Lovato, W. Malorni, G. Rainaldi, P. Mattana, G. Viscomi, M. C. Ingletti, M. Portolani, et al. 1995. Sendai virus and herpes virus type 1 induce apoptosis in human peripheral blood mononuclear cells. Exp. Cell Res. 218: 63-70.
31. Rescigno, M., M. Martino, C. L. Sutherland, M. R. Gold, and P. Ricciardi-Castagnoli. 1998. Dendritic cell survival and maturation are regulated by different signaling pathways. J. Exp. Med. 188: 2175-2180.
32. Speirs, K., L. Lieberman, J. Caamano, C. A. Hunter, and P. Scott. 2003. Cutting edge: NF-κB2 is a negative regulator of dendritic cell function. J. Immunol. 172: 752-756.
33. Neumann, M., H. Fries, C. Scheicher, P. Keikavoussi, A. Kolb-Maurer, E. Brocker, E. Serfling, and E. Kampgen. 2000. Differential expression of Rel/NF-κB and octamer factors is a hallmark of the generation and maturation of dendritic cells. Blood 95: 277-285.
34. Yoshimura, S., J. Bondeson, B. M. Foxwell, F. M. Brennan, and M. Feldmann. 2001. Effective antigen presentation by dendritic cells is NF-κB dependent: coordinate regulation of MHC, co-stimulatory molecules and cytokines. Int. Immunol. 13: 675-683.
35. + peripheral blood progenitor cells. Blood 103: 538-544.
36. Nencioni, A., F. Grunebach, A. Zobywlaski, C. Denzlinger, W. Brugger, and P. Brossart. 2002. Dendritic cell immunogenicity is regulated by peroxisome proliferator-activated receptor γ. J. Immunol. 169: 1228-1235.
37. Salio, M., M. Cella, M. Suter, and A. Lanzavecchia. 1999. Inhibition of dendritic cell maturation by herpes simplex virus. Eur. J. Immunol. 29: 3245-3253.
38. Plotnicky-Gilquin, H., D. Cyblat, J. P. Aubry, Y. Delneste, A. Blaecke, J. Y. Bonnefoy, N. Corvaia, and P. Jeannin. 2001. Differential effects of parainfluenza virus type 3 on human monocytes and dendritic cells. Virology 285: 82-90.
39. Bartz, H., O. Turkel, S. Hoffjan, T. Rothoeft, A. Gonschorek, and U. Schauer. 2003. Respiratory syncytial virus decreases the capacity of myeloid dendritic cells to induce interferon-gamma in naive T cells. Immunology 109: 49-57.
40. Klagge, I. M., V. ter Meulen, and S. Schneider-Schaulies. 2000. Measles virus-induced promotion of dendritic cell maturation by soluble mediators does not overcome the immunosuppressive activity of viral glycoproteins on the cell surface. Eur. J. Immunol. 30: 2741-2750.
41. Servet-Delprat, C., P. O. Vidalain, H. Valentin, and C. Rabourdin-Combe. 2003. Measles virus and dendritic cell functions: how specific response cohabits with immunosuppression. Curr. Top. Microbiol. Immunol. 276: 103-123.
42. Servet-Delprat, C., P. O. Vidalain, H. Bausinger, S. Manie, F. Le Deist, O. Azocar, D. Hanau, A. Fischer, and C. Rabourdin-Combe. 2000. Measles virus induces abnormal differentiation of CD40 ligand-activated human dendritic cells. J. Immunol 164: 1753-1760.
43. Vidalain, P. O., O. Azocar, B. Lamouille, A. Astier, C. Rabourdin-Combe, and C. Servet-Delprat. 2000. Measles viras induces functional TRAIL production by human dendritic cells. J. Virol. 74: 556-559.
44. Bieback, K., E. Lien, I. M. Klagge, E. Avota, J. Schneider-Schaulies, W. P. Duprex, H. Wagner, C. J. Kirschning, V. ter Meulen, and S. Schneider-Schaulies. 2002. Hemagglutinin protein of wild-type measles viras activates Toll-like receptor 2 signaling. J. Virol. 76: 8729-8736.
45. Finke S., R. Mueller-Waldeck, and K. K. Conzelmann. Rabies virus matrix protein regulates the balance of viras transcription and replication. J. Gen. Virol. 84: 1613-1621.
46. Stricker, R., G. Mottet, and L. Roux, 1994. The Sendai virus matrix protein appears to be recruited in the cytoplasm by the viral nucleocapsid to function in viral assembly and budding. J. Gen. Virol. 75: 1031-1042.
47. Sanderson, C. M., H. H. Wu, and D. P. Nayak. 1994. Sendai virus M protein binds independently to either the F or the HN glycoprotein in vivo. J. Virol. 68: 69-76.
48. Ogino, T., M. Iwama, Y. Ohsawa, and K. Mizumoto. 2003. Interaction of cellular tubulin with Sendai virus M protein regulates transcription of viral genome. Biochem. Biophys. Res. Commun. 311: 283-293.
49. Uronen-Hansson, H., J. Allen, M. Osman, G. Squires, N. Klein, and R. E. Callard. 2004. Toll-like receptor 2 (TLR2) and TLR4 are present inside human dendritic cells, associated with microtubules and the Golgi apparatus but are not detectable on the cell surface: integrity of microtubules is required for interleukin-12 production in response to internalized bacteria. Immunology 111: 173-178.
50. Kurt-Jones, E. A., L. Popova, L. Kwinn, L. M. Haynes, L. P. Jones, R. A. Tripp, E. E. Walsh, M. W. Freeman, D. T. Golenbock, L. J. Anderson, and R. W. Finberg. 2000. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1: 398-401.
51. Kirk, C. J., and J. J. Mule. 2000. Gene-modified dendritic cells for use in tumor vaccines. Hum. Gene Ther. 11: 797-806.
52. Inoue, M., Y. Tokusumi, H. Ban, T. Kanaya, M. Shirakura, T. Tokusumi, T. Hirata, Y. Nagai, A. Iida, and M. Hasegawa. 2003. A new Sendai virus vector deficient in the matrix gene does not form virus particles and shows extensive cell-to-cell spreading. J. Virol. 77: 6419-6429.